Categories: News

Autonomous Vehicles, Artificial Intelligence and Automated Laboratories – Are You Ready for Lab Samples to be Delivered by Drones?

SPRINGFIELD, N.J., April 10, 2019 /PRNewswire/ — Hudson Robotics, Inc. announced their collaboration with Physical Sciences Inc. (PSI) to bring drone technology to life science laboratories for sample handling. Microplates containing samples will be delivered to instruments and workcells to perform drug discovery, genomics or quality control assays. As the prime contractor, PSI will develop a system utilizing autonomous drones for moving lab consumables to supplement or replace current automation. Hudson’s President and Founder, Phil Farrelly, said, “Hudson will apply our extensive experience interfacing laboratory devices to develop the hardware and software required to accomplish the project objectives.” Hudson’s software capabilities, SoftLinx™ Laboratory automation software and the associated Plug-ins that control instruments, are crucial to the project.  Hudson will employ those technologies to direct the drones, load and unload the lab instruments, and operate those instruments.

PSI intends to use their own commercial off-the-shelf (COTS) advanced drone technology in conjunction with a new gripper design, to bring this technology to commercialization.  It will provide life science laboratories with the speed, accuracy and reliability required without the associated cost, limited work envelope and operational and support expertise required by existing robotic infrastructure. The goal is to provide a highly flexible microplate transport tool at lower costs than current systems, and to extend lab transport capabilities for longer-distance travel.

Located in Springfield, New Jersey, Hudson Robotics was founded in 1983 and is a leader in robotic automation, microplate handling, laboratory robotics, liquid handling and customized software-driven solutions for life-science research. The company provides tools that can be used in areas such as drug discovery, clinical research and pharmaceutical development, including high throughput screening, proteomics and genomics.

Founded in 1973, Physical Sciences Inc., headquartered in Andover MA, invents, develops and transitions advanced technology solutions and innovative products from the laboratory to commercial and government use.

For more information on Hudson Robotics, Inc., please contact:
Bruce Jamieson
VP, Sales & Marketing
Hudson Robotics, Inc.
bjamieson@hudsonrobotics.com
+1 408-813-2344

For more information on Physical Sciences, Inc., please contact:
Dr. Shin-Juh Chen
Area Manager, Industrial Sensors
schen@psicorp.com
Physical Sciences Inc.
Telephone: (978) 689-0003

This project has been funded in whole or in part with Federal funds from the National Center for Advancing Translational Sciences, National Institutes of Health, Department of Health and Human Services, under Contract No. 75N95019C00011.

View original content:http://www.prnewswire.com/news-releases/autonomous-vehicles-artificial-intelligence-and-automated-laboratories—are-you-ready-for-lab-samples-to-be-delivered-by-drones-300827974.html

SOURCE Hudson Robotics, Inc.

Staff

Recent Posts

Humana Redefines the Member Experience with Agent Assist Built with Google Cloud

Humana introduces Agent Assist to help member advocates deliver faster, more personalized support, enabled by…

2 hours ago

AssureCare Announces Parth Shah’s Promotion to Senior Vice President of Customer Success and Enterprise AI Delivery

CINCINNATI, Feb. 3, 2026 /PRNewswire/ -- AssureCare® LLC, a leading healthcare technology company delivering an…

2 hours ago

Doxim Scales Utility Payments Team to Support Rapid Market Growth

Doxim's Utility Payments Team will drive seamless, omnichannel billing-to-payments solutions for utilities to bridge the…

2 hours ago

Amplifire Recognized by Brandon Hall Group for Breakthrough AI Authoring Technology

BOULDER, Colo., Feb. 3, 2026 /PRNewswire/ -- Amplifire, the leading adaptive learning platform built on patented…

2 hours ago

Cognision Launches Cognision360™: A Unified Platform Transforming Neurobiomarker Acquisition, Processing, and Analysis in CNS Clinical Trials

LOUISVILLE, Ky., Feb. 3, 2026 /PRNewswire/ -- Cognision today unveiled Cognision360™, a groundbreaking web-based platform that consolidates…

2 hours ago